WO2010058796A1 - Leak detection system - Google Patents

Leak detection system Download PDF

Info

Publication number
WO2010058796A1
WO2010058796A1 PCT/JP2009/069564 JP2009069564W WO2010058796A1 WO 2010058796 A1 WO2010058796 A1 WO 2010058796A1 JP 2009069564 W JP2009069564 W JP 2009069564W WO 2010058796 A1 WO2010058796 A1 WO 2010058796A1
Authority
WO
WIPO (PCT)
Prior art keywords
extravasation
patient
information
leak detection
detection system
Prior art date
Application number
PCT/JP2009/069564
Other languages
French (fr)
Japanese (ja)
Inventor
茂 根本
正博 榊原
Original Assignee
株式会社根本杏林堂
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社根本杏林堂 filed Critical 株式会社根本杏林堂
Priority to JP2010539240A priority Critical patent/JP5897798B2/en
Publication of WO2010058796A1 publication Critical patent/WO2010058796A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16831Monitoring, detecting, signalling or eliminating infusion flow anomalies
    • A61M5/16836Monitoring, detecting, signalling or eliminating infusion flow anomalies by sensing tissue properties at the infusion site, e.g. for detecting infiltration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0468Liquids non-physiological
    • A61M2202/049Toxic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3306Optical measuring means
    • A61M2205/3313Optical measuring means used specific wavelengths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3546Range
    • A61M2205/3561Range local, e.g. within room or hospital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Definitions

  • the present invention relates to a leakage detection system for detecting extravasation during the administration of a drug solution to a patient, and in particular, the patient moves during administration of a drug solution, and the blood vessel is moved at the destination.
  • An object of the present invention is to provide a leak detection system that can detect a leak even if an external leak occurs.
  • the patient may go to a toilet or the like while instilling. Therefore, there is a possibility that the tip of the injection needle is detached from the blood vessel at a place other than the hospital room and extravasation occurs. If the drug solution is a nutrient, etc., extravasation may occur, and even if the drug solution is injected subcutaneously, the effect on the human body is relatively small. There is a risk that the tissue becomes hard or in some cases necrotic. Therefore, it is desirable to detect such extravasation as soon as possible.
  • Patent Document 1 includes a light emitting element that emits light toward the vicinity of a blood vessel, and a light receiving element that receives the reflected light.
  • a device used by being attached to an arm (one example) is disclosed.
  • an object of the present invention is to provide a leak detection system that can detect a leak well even when a patient moves during administration of a drug solution and an extravasation occurs at the destination.
  • the leak detection system of the present invention includes: A leak detection device for detecting extravasation when administering a liquid medicine to a patient; A monitoring terminal located in the hospital facility; Transmitting means for wirelessly transmitting extravasation information detected by the leak detection device to the monitoring terminal.
  • the transmission means for wirelessly transmitting extravasation information since the transmission means for wirelessly transmitting extravasation information is provided, the patient moves out of the hospital room while the drug solution is being administered. Even when extravasation occurs, the leak can be detected well.
  • administering a drug solution is intended to have a relatively slow infusion rate such as administration by infusion or administration using a drug solution pump (detailed later). It is intended that the patient moves out of the room during administration and extravasation may occur at the destination (outside the room, etc.).
  • system of the present invention may further have a function of storing a time from the start of the drug solution administration to the occurrence of the extravasation. In this case, since the amount of the chemical solution that has already been introduced can be estimated, it is possible to satisfactorily determine the remaining amount to be administered when the administration of the chemical solution is resumed.
  • a plurality of relays that receive information transmitted from the transmitting means and send the information to the monitoring terminal are arranged in a hospital facility, and as the patient position information, Position information of the repeater is sent to the monitoring terminal. Moreover, when the said repeater is arrange
  • the infusion pump of the present invention is an infusion pump for administering a drug solution to a patient, A receiving unit for receiving information on the extravasation transmitted from the leak detection device for detecting extravasation when administering a drug solution to a patient; A transmission unit that wirelessly transmits the extravasation information to a monitoring terminal disposed in the hospital facility.
  • the system of the “infusion pump” is not particularly limited, and may be a finger pump, a roller pump, a syringe pump, or the like.
  • the various means referred to in the present invention need only be formed so as to realize the function.
  • dedicated hardware that exhibits a predetermined function
  • a data processing apparatus provided with a predetermined function by a computer program
  • It can be realized as a predetermined function implemented in the data processing apparatus by a computer program, a combination thereof, or the like.
  • the various constituent elements referred to in the present invention do not necessarily have to be individually independent, and a plurality of constituent elements are formed as one member, and one constituent element is formed from a plurality of members. It is possible that a certain component is a part of another component, a part of a certain component overlaps a part of another component, and the like.
  • the leak detection system can detect the leak well. Can be provided.
  • FIG. 1 It is a figure which shows the leak detection system of one Embodiment of this invention. It is a figure which shows a chemical
  • FIG. 1 is a diagram showing a leakage detection system according to an embodiment of the present invention, and shows an example in which a system is constructed in a hospital facility.
  • FIG. 2 is a diagram illustrating a chemical solution bag and a leakage detection unit.
  • this leak detection system 1 is used in a hospital facility as an example, and a leak detection unit 20 (for detecting extravasation when a drug solution is administered to a patient) 2), a plurality of repeaters 30 that are arranged in several places in the hospital facility and receive radio signals, a center console 40 that is arranged in the nurse station and is connected to the repeater 30 by wire or wirelessly, It has.
  • the repeater 30 may be omitted. This will be described later.
  • a drug solution for example, an anticancer drug
  • a drug solution is administered to a patient in a hospital room 201.
  • the drug solution is accommodated in a drug solution bag 83 suspended from the upper part of the movable stand 81, and is administered to the blood vessel of the patient's arm via the tube 85. Since the stand 81 is movable, the patient can leave the hospital room 201 (see FIG. 1) and go to the toilet 204, for example, even during the administration of the drug solution.
  • the leakage detection unit 20 includes a flat circular housing 21, a substrate 22 and a coin-type battery 23 (for example, a lithium secondary battery) disposed therein.
  • a light emitting diode that irradiates light around the blood vessel of the patient and a phototransistor that detects the reflected light are disposed downward.
  • a conventionally well-known thing can be utilized for these leak detection devices. Light rays from the light emitting diodes are applied to the patient's skin through an opening in the bottom surface of the housing 21.
  • the light emitting diode may emit infrared rays.
  • the principle of detecting extravasation using infrared light is the same as that described in Patent Document 1 (WO 2006-030764) and the like, and will be briefly described below.
  • FIG. 4A the intensity of the wavelength band of the reflected light to be detected is equal, but when the chemical liquid leaks, FIG. As shown in FIG. 4, the detected reflected light is extremely lowered only at a specific wavelength.
  • the detection unit 20 determines whether extravasation has occurred based on this difference.
  • the substrate 22 is also mounted with a control circuit that performs predetermined arithmetic processing and a wireless antenna 22a that transmits to the outside that an extravasation has occurred.
  • a wireless system for example, the Zigbee (registered trademark) standard using a frequency band of 2.45 GHz can be used from the viewpoint of power consumption and the like.
  • the center console 40 is a monitoring terminal and is arranged in each of the nurse stations 108 and 208 as shown in FIG. Although illustration is omitted, the center console 40 includes a display (display means) for displaying a warning message when information on extravasation is received. Each center console 40 may be mutually connected by LAN, for example.
  • the repeater 30 is arranged on a plurality of floors of a hospital facility. In this example, they are arranged in a hospital room 201 and a toilet 204 where a medical solution is administered to a patient, and a patient room 101 and a toilet 104 on the floor below.
  • the repeater 30 may be attached near the ceiling, for example.
  • the repeater 30 has a function of receiving a radio signal from the detection unit 20 when extravasation occurs and a function of sending the information to the center console 40. Communication between the repeater 30 and the center console 40 may be wired communication or wireless communication.
  • the position information of the repeaters is stored in advance in each repeater 30.
  • the position information is also sent to the console 40.
  • the positional information is displayed on the display of the console 40 together with the fact that extravasation has occurred.
  • the information may be sent directly from the detection unit 20 to the center console 40 without the relay 30 being interposed.
  • the patient enters the hospital room 201, and the injection needle at the tip of the tube 85 is inserted into the blood vessel (an example) of the arm. Then, the detection unit 20 is arranged from above so that extravasation can be detected (see FIG. 2), and then administration of the drug solution is started.
  • the method for fixing the detection unit 20 to the patient's arm is not particularly limited, and the unit 20 may be fixed by a transparent double-sided sheet 29 as shown in FIG. The unit 20 may be fixed by using (shown).
  • the drug solution is administered subcutaneously.
  • the leak detection unit 20 emits infrared light of a predetermined wavelength band with a light emitting diode near the position where the injection needle is inserted into the blood vessel, and detects the reflected light with a phototransistor. Specifically, as in the conventional configuration, the intensity of a specific wavelength is measured among infrared rays in a predetermined wavelength band to be detected, and the average intensity of the wavelength band is also measured. The ratio of the intensity of the specific wavelength to the average intensity of the light beam in the wavelength band thus measured is calculated, and the calculated ratio is compared with a predetermined reference value.
  • the leakage detection unit transmits, as an example, a standby signal (wireless signal) indicating “no leakage”.
  • a standby signal wireless signal
  • the leakage detection unit 20 transmits a warning signal (radio signal) indicating “leak occurrence” to the outside via the antenna 22a.
  • the extravasation information transmitted from the detection unit 20 is received by the toilet relay 30 and sent to the console 40 in the nurse station 201 via the relay 30. At this time, the position information stored in advance in the repeater 30 is also sent to the console 40.
  • the console 40 Upon receiving the above information, the console 40 displays on the display that extravasation has occurred and the position information of the patient at the time of occurrence (position of the relay 30).
  • the signal from the detection unit 20 is received by the predetermined repeater 30 on the first floor as described above.
  • Information is sent to the console 40 in the nurse station 108 via the repeater 30.
  • the leakage of the drug solution to the outside of the blood vessel is minimized, and damages such as tissue hardening and necrosis are prevented. This is advantageous in that it can be prevented.
  • the repeater 30 since the repeater 30 is also arranged in the hospital room 201, it is natural that the extravasation in the hospital room 201 can be notified to the nurse in the nurse station 208. For example, when an infusion is performed during sleep, extravasation caused by the injection needle coming off the blood vessel while sleeping can also be detected.
  • the position information at the time when extravasation occurs may be recognized by the detection unit 20 itself, and the information may be transmitted to the console 40.
  • ID data for each patient is also transmitted from the detection unit 20 in order to identify the patient.
  • the console 40 is provided on each floor, and information from the detection unit 20 is received by the console 40 on the floor where the unit 20 exists (the floor where the patient is present). Even if it is not possible to specify the detailed position of the patient, it is possible to specify at least what floor the patient is on.
  • the detection unit 20 may be provided with alarm means such as an LED or a speaker, and the alarm means may be driven when the unit 20 detects extravasation.
  • alarm means such as an LED or a speaker
  • the present system 1 may further have a function of storing the time from the start of drug administration to the occurrence of extravasation. According to such a configuration, when the administration of the drug solution is resumed, it is possible to satisfactorily determine how much of the remaining amount should be administered.
  • the detection unit 20 itself has a function of measuring the time, and the occurrence of extravasation from the start of drug administration The time until the time is measured and the information may be transmitted to the console 40.
  • the console 40 may be able to measure the time from the start of drug solution administration to the occurrence of extravasation. This time information may be stored in the unit 20 or the console 40 as required.
  • FIG. 5 is a diagram illustrating a part of the leakage detection system according to the second embodiment. As shown in FIG. 5, this invention is applicable also when administering a chemical
  • This chemical pump 90 is a finger pump (one example) that is used by being attached to a stand 81, and includes a display 93 that displays predetermined information such as a flow rate, a finger portion that pressurizes a tube, a built-in battery, etc., not shown. Have. Moreover, a bubble sensor, a pressure sensor, a drop sensor, etc. may be incorporated.
  • the chemical pump 90 includes a calculation unit 91 that performs various calculations, a reception unit 95 that is connected to the leak detection unit 20 by wire or wirelessly and receives information on extravasation from the unit 20, It has the transmission part 93 which transmits the information of extravascular leakage to the exterior by radio
  • the information on extravasation from the detection unit 20 is received by the receiving unit 95, and the information is transmitted to the console 40 (see FIG. 1) via the transmitting unit 93.
  • the calculation unit 91 may be configured to send a drive stop signal to the drive unit 97.
  • the infusion pump 90 may have a function of transmitting the position information of the patient in the hospital facility at the time when the extravasation occurs together with the extravasation information as in the first embodiment. .
  • FIG. 5 shows a configuration in which the infusion pump 90 and the leak detection unit 20 are connected to each other by a cord 28.
  • the built-in battery of the infusion pump 90 can also be used as a power source for the detection unit 20. Further, when extravasation occurs, that fact may be displayed on the display 93 of the infusion pump 90.
  • FIG. 7 is a diagram showing a charging device 120 for the built-in battery 23 of the leakage detection unit 20 shown in FIG.
  • the charging device 120 is a non-contact type charger that charges a battery in the detection unit 20 using electromagnetic induction.
  • the charging device 120 includes a substantially plate-shaped holding unit 122 in which a plurality of detection units 20 can be arranged.
  • a power transmission coil (not shown) is built in the holding unit 122, and a power reception coil 27 (see FIG. 3) is built in one detection unit 20.
  • non-contact type charging device it is not necessary to provide a metal contact for charging in the leakage detection unit 20, and therefore, it is particularly suitable for the unit 20 of the present embodiment that detects leakage of a chemical solution.
  • the plate-shaped holding part 122 of the charging device 120 may be provided with a recess into which each unit 20 is fitted, or may be provided with an indicator such as an LED that indicates completion of charging.
  • the leak detection unit 20 may transmit a warning signal only when extravasation occurs, or indicates “no leak” even if no extravasation occurs as in the above embodiment. It may be configured to transmit a standby signal.
  • the leakage detection unit 20 and the plurality of repeaters 30 can be connected using wireless communication.
  • the positional relationship with several units may be calculated, and the patient position information may be acquired by performing surveying based on the calculated positional relationship.
  • FIG. 8 is a diagram schematically showing a circuit configuration of a leakage detection unit according to still another embodiment of the present invention.
  • the leak detection unit 20 ′ includes a control unit 26 that performs various calculations, and a leak detection device 26a connected thereto (similar to the first embodiment, a light emitting diode or the like). And a temperature sensor 26b connected to the control unit 26. An optical sensor may be used instead of this temperature sensor.
  • the temperature sensor 26b is disposed on the lower surface side of the unit 20 ′ (see FIG. 3), and measures the temperature of the patient's body surface when the unit 20 ′ is normally attached to the patient's body. When the unit 20 'is removed from the patient's body for some reason (separated), the temperature sensor 26b measures the temperature of the outside air (one example) instead of the body surface. By using this detection result by the temperature sensor 26b, it is possible to detect whether or not the unit 20 'is normally attached to the patient's body.
  • the following determination can be performed by using the leakage detection unit 20 ′ having the above configuration.

Abstract

Provided is a leak detection system which can effectively detect a leak even when a patient has moved during administration of a chemical liquid and the movement has caused a leak of the chemical liquid out of a blood vessel.  The leak detection system (1) includes: a leak detection device (20) which detects a leak out of a blood vessel during administration of a chemical liquid to a patient; and a transmission means which radio-transmits to a monitor terminal, the information relating to the leak out of the blood vessel detected by the leak detection device (20).

Description

漏出検出システムLeak detection system
 本発明は、患者に対し薬液を投与している最中の血管外漏出を検出するための漏出検出システムに関し、特には、薬液を投与している最中に患者が移動し、移動先で血管外漏出が発生したとしてもその漏出を良好に検出できる漏出検出システムを提供することにある。 The present invention relates to a leakage detection system for detecting extravasation during the administration of a drug solution to a patient, and in particular, the patient moves during administration of a drug solution, and the blood vessel is moved at the destination. An object of the present invention is to provide a leak detection system that can detect a leak even if an external leak occurs.
 従来、点滴により栄養剤などの薬液を患者に投与する場合、例えば1時間~数時間といった比較的長い時間の投与が必要である。また、このような薬液投与においては、投与している最中に注入針の先端が血管から外れてしまい薬液が皮下に投与されること場合がある(これを「血管外漏出」という)。 Conventionally, when a medicinal solution such as a nutrient is administered to a patient by infusion, it needs to be administered for a relatively long time, for example, 1 hour to several hours. In addition, in such drug solution administration, the tip of the injection needle may be detached from the blood vessel during administration, and the drug solution may be administered subcutaneously (this is referred to as “extravascular leakage”).
 一方、このような長時間の薬液投与においては、患者が点滴をしたままトイレ等に行く場合がある。そのため、病室以外の場所で注入針の先端が血管から外れてしまい血管外漏出が発生する可能性もあった。
 薬液が栄養剤などの場合、血管外漏出が発生し薬液が皮下に注入されたとしても人体に対する影響は比較的小さいが、薬液が抗ガン剤の場合、注入された部分の皮膚に炎症が起き、組織が硬くなったり、場合によっては壊死したりするおそれがある。したがって、このような血管外漏出はできるだけ早急に検出されることが望ましい。
On the other hand, in such long-term drug administration, the patient may go to a toilet or the like while instilling. Therefore, there is a possibility that the tip of the injection needle is detached from the blood vessel at a place other than the hospital room and extravasation occurs.
If the drug solution is a nutrient, etc., extravasation may occur, and even if the drug solution is injected subcutaneously, the effect on the human body is relatively small. There is a risk that the tissue becomes hard or in some cases necrotic. Therefore, it is desirable to detect such extravasation as soon as possible.
 ところで、上記のような血管外漏出を検出する手段としては、例えば特許文献1に、血管付近に向けて光線を発光する発光素子と、その反射光を受光する受光素子とを有し、患者の腕(一例)に貼り付けられて使用されるデバイスが開示されている。 By the way, as means for detecting extravasation as described above, for example, Patent Document 1 includes a light emitting element that emits light toward the vicinity of a blood vessel, and a light receiving element that receives the reflected light. A device used by being attached to an arm (one example) is disclosed.
WO2006-030764WO2006-030764
 特許文献1記載の従来の漏出検出手段においては、薬液(例えば造影剤)の血管外漏出を良好に検出することが可能であるが、薬液の注入中に患者が移動して病室外に出ることは想定していない。
 そこで、本発明の目的は、薬液を投与している最中に患者が移動し、移動先で血管外漏出が発生したとしてもその漏出を良好に検出できる漏出検出システムを提供することにある。
In the conventional leak detection means described in Patent Document 1, it is possible to detect the extravasation of the drug solution (for example, contrast medium) well, but the patient moves out of the room while the drug solution is being injected. Is not assumed.
Accordingly, an object of the present invention is to provide a leak detection system that can detect a leak well even when a patient moves during administration of a drug solution and an extravasation occurs at the destination.
 上記目的を達成するため、本発明の漏出検出システムは、
 患者に対し薬液を投与している際の血管外漏出を検出する漏出検出装置と、
 病院施設内に配置された監視端末と、
 前記漏出検出装置によって検出された血管外漏出の情報を無線により前記監視端末へ送信する送信手段と、を備える。
In order to achieve the above object, the leak detection system of the present invention includes:
A leak detection device for detecting extravasation when administering a liquid medicine to a patient;
A monitoring terminal located in the hospital facility;
Transmitting means for wirelessly transmitting extravasation information detected by the leak detection device to the monitoring terminal.
 上記本発明の漏出検出システムによれば、管外漏出の情報を無線により送信する送信手段を備えているので、仮に薬液を投与している最中に患者が病室外に移動し、移動先で血管外漏出が発生した場合であっても、その漏出を良好に検出することができる。 According to the leak detection system of the present invention, since the transmission means for wirelessly transmitting extravasation information is provided, the patient moves out of the hospital room while the drug solution is being administered. Even when extravasation occurs, the leak can be detected well.
 なお、本明細書でいう「薬液を投与」とは、点滴による投与や薬液ポンプ(詳細後述)を用いた投与といった注入速度が比較的遅いものを意図しており、具体的には、薬液の投与中に患者が病室の外に移動し、移動先で(病室の外など)で血管外漏出が発生しうるようなものを意図している。 As used herein, “administering a drug solution” is intended to have a relatively slow infusion rate such as administration by infusion or administration using a drug solution pump (detailed later). It is intended that the patient moves out of the room during administration and extravasation may occur at the destination (outside the room, etc.).
 また、本発明のシステムは、さらに、前記薬液投与の開始から前記血管外漏出の発生までの時間を記憶する機能を有していてもよい。
 この場合、既に投入された薬液の量を推測できるので、薬液の投与を再開する際に残りどれくらいの量を投与すればよいかを良好に決定することができる。
In addition, the system of the present invention may further have a function of storing a time from the start of the drug solution administration to the occurrence of the extravasation.
In this case, since the amount of the chemical solution that has already been introduced can be estimated, it is possible to satisfactorily determine the remaining amount to be administered when the administration of the chemical solution is resumed.
 また、本発明の他のシステムでは、前記送信手段から送信された情報を受信して該情報を前記監視端末に送る中継器が病院施設内に複数配置されており、前記患者の位置情報として、該中継器の位置情報が前記監視端末に送られる。
 また、前記中継器が病院施設内の複数階に配置されている場合、患者が他の階に移動したとしても患者の位置を検出できるという利点がある。
Further, in another system of the present invention, a plurality of relays that receive information transmitted from the transmitting means and send the information to the monitoring terminal are arranged in a hospital facility, and as the patient position information, Position information of the repeater is sent to the monitoring terminal.
Moreover, when the said repeater is arrange | positioned in the several floor in a hospital facility, even if a patient moves to another floor, there exists an advantage that a patient's position can be detected.
 本発明の輸液ポンプは、患者に対し薬液を投与するための輸液ポンプであって、
 患者に対し薬液を投与している際の血管外漏出を検出するための漏出検出装置から送信された前記血管外漏出の情報を受ける受信部と、
 前記血管外漏出の情報を無線により病院施設内に配置された監視端末に送信する送信部と、を備える。
 ここで、「輸液ポンプ」とは、その方式は特に限定されるものではなく、例えば、フィンガーポンプ、ローラーポンプ、シリンジポンプ等であってもよい。
The infusion pump of the present invention is an infusion pump for administering a drug solution to a patient,
A receiving unit for receiving information on the extravasation transmitted from the leak detection device for detecting extravasation when administering a drug solution to a patient;
A transmission unit that wirelessly transmits the extravasation information to a monitoring terminal disposed in the hospital facility.
Here, the system of the “infusion pump” is not particularly limited, and may be a finger pump, a roller pump, a syringe pump, or the like.
 なお、本発明で云う各種手段は、その機能を実現するように形成されていれば良く、例えば、所定の機能を発揮する専用のハードウェア、所定の機能がコンピュータプログラムにより付与されたデータ処理装置、コンピュータプログラムによりデータ処理装置に実現された所定の機能、これらの組み合わせ、等として実現することができる。 The various means referred to in the present invention need only be formed so as to realize the function. For example, dedicated hardware that exhibits a predetermined function, a data processing apparatus provided with a predetermined function by a computer program It can be realized as a predetermined function implemented in the data processing apparatus by a computer program, a combination thereof, or the like.
 また、本発明で云う各種の構成要素は、かならずしも個々に独立した存在である必要はなく、複数の構成要素が1個の部材として形成されていること、1つの構成要素が複数の部材で形成されていること、ある構成要素が他の構成要素の一部であること、ある構成要素の一部と他の構成要素の一部とが重複していること、等も可能である。 In addition, the various constituent elements referred to in the present invention do not necessarily have to be individually independent, and a plurality of constituent elements are formed as one member, and one constituent element is formed from a plurality of members. It is possible that a certain component is a part of another component, a part of a certain component overlaps a part of another component, and the like.
 上述したように本発明によれば、薬液を投与している最中に患者が移動し、移動先で血管外漏出が発生した場合であっても、その漏出を良好に検出可能な漏出検出システムを提供することができる。 As described above, according to the present invention, even when a patient moves during administration of a medical solution and an extravasation occurs at the movement destination, the leak detection system can detect the leak well. Can be provided.
本発明の一実施形態の漏出検出システムを示す図である。It is a figure which shows the leak detection system of one Embodiment of this invention. 薬液バッグや漏出検出ユニットを示す図である。It is a figure which shows a chemical | medical solution bag and a leak detection unit. 漏出検出ユニットの構造を示す分解図である。It is an exploded view which shows the structure of a leak detection unit. 血管外漏出が発生した場合の反射光の強度の変化を示すグラフである。It is a graph which shows the change of the intensity | strength of reflected light when extravascular leakage has occurred. 第2の実施形態の構成を示す図である。It is a figure which shows the structure of 2nd Embodiment. 輸液ポンプの概略的なブロック図である。It is a schematic block diagram of an infusion pump. 電磁誘導式の充電装置の一例を示す図である。It is a figure which shows an example of an electromagnetic induction type charging device. 他の形態の漏出検出ユニットの模式的なブロック図である。It is a typical block diagram of the leak detection unit of other forms.
 以下、図面を参照して本発明の実施の一形態を説明する。
(第1の実施形態)
 図1は、本発明の一実施形態の漏出検出システムを示す図であり、病院施設内にシステムが構築された例を示している。図2は、薬液バッグや漏出検出ユニットを示す図である。
Hereinafter, an embodiment of the present invention will be described with reference to the drawings.
(First embodiment)
FIG. 1 is a diagram showing a leakage detection system according to an embodiment of the present invention, and shows an example in which a system is constructed in a hospital facility. FIG. 2 is a diagram illustrating a chemical solution bag and a leakage detection unit.
 なお、以下の説明では、図面の記載に合わせて、「上下」、「左右」等の方向を示す語句を用いることがあるが、これらは本発明を何ら限定するものではない。また、注入針が刺される位置等についても当然ながら図2に限定されるものではない。 In the following description, words indicating directions such as “up and down” and “left and right” may be used in accordance with the description of the drawings, but these do not limit the present invention. Also, the position where the injection needle is inserted is not limited to that shown in FIG.
 図1に示すように、この漏出検出システム1は一例として病院施設内で使用されるものであり、患者に対し薬液を投与している際の血管外漏出を検出するための漏出検出ユニット20(図2参照)と、病院施設内の数箇所に配置され無線信号を受信する複数の中継器30と、ナースステーション内に配置され該中継器30と有線又は無線で接続されたセンターコンソール40と、を備えている。
 なお、本発明のシステムにおいて、中継器30を省略した構成とすることも可能であるが、これについては後述する。
As shown in FIG. 1, this leak detection system 1 is used in a hospital facility as an example, and a leak detection unit 20 (for detecting extravasation when a drug solution is administered to a patient) 2), a plurality of repeaters 30 that are arranged in several places in the hospital facility and receive radio signals, a center console 40 that is arranged in the nurse station and is connected to the repeater 30 by wire or wirelessly, It has.
In the system of the present invention, the repeater 30 may be omitted. This will be described later.
 本実施形態では一例として、病室201において患者に対して薬液(例えば抗ガン剤)が投与される。薬液は、図2に示すように、可動式のスタンド81の上部に吊るされた薬液バッグ83内に収容されており、チューブ85を介して患者の腕の血管へと投与される。スタンド81が可動式であるため、患者は、薬液投与の最中であっても病室201(図1参照)を出て例えばトイレ204などに行くことができる。 In this embodiment, as an example, a drug solution (for example, an anticancer drug) is administered to a patient in a hospital room 201. As shown in FIG. 2, the drug solution is accommodated in a drug solution bag 83 suspended from the upper part of the movable stand 81, and is administered to the blood vessel of the patient's arm via the tube 85. Since the stand 81 is movable, the patient can leave the hospital room 201 (see FIG. 1) and go to the toilet 204, for example, even during the administration of the drug solution.
 漏出検出ユニット20は、図2、図3に示すように、平たい円形のハウジング21と、その内部に配置された基板22およびコイン型電池23(例えばリチウム二次電池)等を有している。基板22の下面には、患者の血管周辺に向けて光線を照射する発光ダイオードと、その反射光を検出するフォトトランジスタとが下向きに配置されている。なお、これらの漏出検出用デバイスは従来公知のものを利用することができる。発光ダイオードからの光線は、ハウジング21の底面の開口を通って患者の皮膚に照射される。 As shown in FIGS. 2 and 3, the leakage detection unit 20 includes a flat circular housing 21, a substrate 22 and a coin-type battery 23 (for example, a lithium secondary battery) disposed therein. On the lower surface of the substrate 22, a light emitting diode that irradiates light around the blood vessel of the patient and a phototransistor that detects the reflected light are disposed downward. In addition, a conventionally well-known thing can be utilized for these leak detection devices. Light rays from the light emitting diodes are applied to the patient's skin through an opening in the bottom surface of the housing 21.
 発光ダイオードは赤外線を出射するものであってもよい。赤外光を利用して血管外漏出を検出する原理については特許文献1(WO2006-030764)等に記載されたものと同様であるので、以下、簡単に説明する。患者の腕の皮下に薬液が漏出していない状態では、図4(a)に示すように、検出される反射光の波長帯域の強度は均等となるが、薬液が漏出すると図4(b)に示すように、検出される反射光は特定波長の部分のみ極端に低下する。検出ユニット20は、この差に基づいて、血管外漏出が発生したか否かを判定する。 The light emitting diode may emit infrared rays. The principle of detecting extravasation using infrared light is the same as that described in Patent Document 1 (WO 2006-030764) and the like, and will be briefly described below. In the state where no chemical liquid leaks under the arm of the patient, as shown in FIG. 4A, the intensity of the wavelength band of the reflected light to be detected is equal, but when the chemical liquid leaks, FIG. As shown in FIG. 4, the detected reflected light is extremely lowered only at a specific wavelength. The detection unit 20 determines whether extravasation has occurred based on this difference.
 基板22には、また、所定の演算処理を行う制御回路や、血管外漏出が発生したことを無線により外部に送信する無線アンテナ22aが実装されている。無線方式としては、消費電力等の観点から、例えば、2.45GHzの周波数帯を用いるZigbee(登録商標)規格を利用することができる。 The substrate 22 is also mounted with a control circuit that performs predetermined arithmetic processing and a wireless antenna 22a that transmits to the outside that an extravasation has occurred. As a wireless system, for example, the Zigbee (registered trademark) standard using a frequency band of 2.45 GHz can be used from the viewpoint of power consumption and the like.
 センターコンソール40は監視端末であり、図1に示すように、各ナースステーション108、208内に配置されている。図示は省略するが、センターコンソール40は、血管外漏出の情報を受信した際に警告メッセージを表示するためのディスプレイ(表示手段)等を有している。各センターコンソール40は、例えばLANにより相互に接続されていてもよい。 The center console 40 is a monitoring terminal and is arranged in each of the nurse stations 108 and 208 as shown in FIG. Although illustration is omitted, the center console 40 includes a display (display means) for displaying a warning message when information on extravasation is received. Each center console 40 may be mutually connected by LAN, for example.
 図1に示すように、中継器30は、病院施設の複数階に配置されている。この例では、患者に対して薬液の投与が行われる病室201やトイレ204、及び、その下のフロアの病室101やトイレ104に配置されている。中継器30は例えば天井付近に取り付けられていてもよい。
 中継器30は、血管外漏出が発生した際に検出ユニット20からの無線信号を受ける機能と、その情報をセンターコンソール40に送る機能を有している。中継器30とセンターコンソール40との間の通信は、有線通信であってもよいし無線通信であってもよい。
As shown in FIG. 1, the repeater 30 is arranged on a plurality of floors of a hospital facility. In this example, they are arranged in a hospital room 201 and a toilet 204 where a medical solution is administered to a patient, and a patient room 101 and a toilet 104 on the floor below. The repeater 30 may be attached near the ceiling, for example.
The repeater 30 has a function of receiving a radio signal from the detection unit 20 when extravasation occurs and a function of sending the information to the center console 40. Communication between the repeater 30 and the center console 40 may be wired communication or wireless communication.
 血管外漏出が発生した時点での病院施設内における患者の位置を認識するため、各中継器30には、それら中継器の位置情報が予め記憶されている。そして、血管外漏出が発生した場合には、その位置情報もコンソール40に送られるようになっている。位置情報は、血管外漏出が発生した旨とともに、コンソール40のディスプレイに表示される。 In order to recognize the position of the patient in the hospital facility at the time when extravasation has occurred, the position information of the repeaters is stored in advance in each repeater 30. When extravasation occurs, the position information is also sent to the console 40. The positional information is displayed on the display of the console 40 together with the fact that extravasation has occurred.
 このような構成により、ナースステーション208内に居るナースに、血管外漏出が発生した時点での病院施設内における患者の位置情報を知らせることができる。なお、中継器30を介在させず、情報(血管外漏出の情報及び患者の位置情報)が検出ユニット20からセンターコンソール40にダイレクトに送られる構成としてもよい。 With such a configuration, it is possible to inform the nurse in the nurse station 208 of the positional information of the patient in the hospital facility at the time when extravasation occurs. The information (extravasation information and patient position information) may be sent directly from the detection unit 20 to the center console 40 without the relay 30 being interposed.
 上記のように構成された本実施形態の漏出検出システム1の動作について、以下、説明する。 The operation of the leak detection system 1 of the present embodiment configured as described above will be described below.
 先ず、患者は病室201に入り、チューブ85先端の注入針が腕の血管(一例)に刺し込まれる。そして、血管外漏出を検出できるように、その上から検出ユニット20が配置され(図2参照)、その後、薬液の投与が開始される。
 なお、検出ユニット20を患者の腕に固定する方法は特に限定されるものではなく、図2に示すような透明な両面シート29によりユニット20を固定してもよいし、又は、バンド等(不図示)を用いてユニット20を固定してもよい。
First, the patient enters the hospital room 201, and the injection needle at the tip of the tube 85 is inserted into the blood vessel (an example) of the arm. Then, the detection unit 20 is arranged from above so that extravasation can be detected (see FIG. 2), and then administration of the drug solution is started.
The method for fixing the detection unit 20 to the patient's arm is not particularly limited, and the unit 20 may be fixed by a transparent double-sided sheet 29 as shown in FIG. The unit 20 may be fixed by using (shown).
 図1に示すように、仮に薬液を投与している最中に患者がトイレ204に向かって移動し、病室外で注入針が血管から外れた場合、薬液は皮下に投与されることとなる。 As shown in FIG. 1, if the patient moves toward the toilet 204 while the drug solution is being administered and the injection needle is removed from the blood vessel outside the hospital room, the drug solution is administered subcutaneously.
 漏出検出ユニット20は、血管に注入針が刺されている位置付近に、発光ダイオードで所定の波長帯域の赤外線を出射するとともに、フォトトランジスタでその反射光を検出する。具体的には、従来の構成同様、検出される所定の波長帯域の赤外線のうち特定波長の強度が測定され、その波長帯域の平均的な強度も測定される。このように測定された波長帯域の光線の平均的な強度に対する特定波長の強度の比率が算出され、その算出された比率が所定の基準値と比較される。比率が基準値より低下していないと薬液の漏出発生は判定されず、漏出検出ユニットは、一例として、「漏出無し」を示す待機信号(無線信号)を送信する。
 一方、上述の比率が基準値より低下していると薬液の漏出発生が判定され、漏出検出ユニット20は、アンテナ22aを介して、「漏出発生」を示す警告信号(無線信号)を外部に送信する。
The leak detection unit 20 emits infrared light of a predetermined wavelength band with a light emitting diode near the position where the injection needle is inserted into the blood vessel, and detects the reflected light with a phototransistor. Specifically, as in the conventional configuration, the intensity of a specific wavelength is measured among infrared rays in a predetermined wavelength band to be detected, and the average intensity of the wavelength band is also measured. The ratio of the intensity of the specific wavelength to the average intensity of the light beam in the wavelength band thus measured is calculated, and the calculated ratio is compared with a predetermined reference value. If the ratio is not lower than the reference value, the occurrence of leakage of the chemical liquid is not determined, and the leakage detection unit transmits, as an example, a standby signal (wireless signal) indicating “no leakage”.
On the other hand, if the ratio is lower than the reference value, the occurrence of leakage of the chemical solution is determined, and the leakage detection unit 20 transmits a warning signal (radio signal) indicating “leak occurrence” to the outside via the antenna 22a. To do.
 検出ユニット20から送信された血管外漏出の情報は、この例では、トイレの中継器30によって受信され、この中継器30を介して、ナースステーション201内のコンソール40に送られる。この際、この中継器30に予め記憶された位置情報も併せてコンソール40へと送られる。 In this example, the extravasation information transmitted from the detection unit 20 is received by the toilet relay 30 and sent to the console 40 in the nurse station 201 via the relay 30. At this time, the position information stored in advance in the repeater 30 is also sent to the console 40.
 上記情報を受けたコンソール40は、血管外漏出が発生したこと、及び、発生した時点の患者の位置情報(当該中継器30の位置)をディスプレイに表示する。 Upon receiving the above information, the console 40 displays on the display that extravasation has occurred and the position information of the patient at the time of occurrence (position of the relay 30).
 患者が例えば下の階(1階)まで移動し、そこで血管外漏出が発生した場合であっても、上記同様、検出ユニット20からの信号が1階の所定の中継器30によって受信され、その中継器30を介して、情報がナースステーション108内のコンソール40に送られる。 Even when the patient moves to the lower floor (the first floor) and an extravasation occurs there, the signal from the detection unit 20 is received by the predetermined repeater 30 on the first floor as described above. Information is sent to the console 40 in the nurse station 108 via the repeater 30.
 以上のような構成によれば、仮に血管外漏出が病室201の外で起きた場合であっても、無線通信により、漏出が発生したことが良好に検出される。また、漏出が発生した位置の情報も知ることができる。したがって、ナースステーション内のナースが早急に患者のところに向かい、血管外漏出の対応を行うことが可能となる。 According to the above configuration, even if extravasation occurs outside the hospital room 201, it is well detected that the leak has occurred by wireless communication. It is also possible to know information on the position where the leak has occurred. Therefore, the nurse in the nurse station can quickly go to the patient and deal with extravasation.
 なお、本実施形態において、位置情報は送信せずに、血管外漏出が発生した旨のみがコンソール40に向けて送られるようになっていてもよい。 In the present embodiment, only the fact that extravasation has occurred may be sent to the console 40 without transmitting the position information.
 本実施形態のシステム1によれば、特に、抗ガン剤等の投与において血管外漏出が発生した場合に、血管外への薬液の漏出を最小限に抑え、組織の硬化や壊死等の被害を防止できる点で有利である。 According to the system 1 of the present embodiment, particularly when an extravasation occurs in the administration of an anticancer agent or the like, the leakage of the drug solution to the outside of the blood vessel is minimized, and damages such as tissue hardening and necrosis are prevented. This is advantageous in that it can be prevented.
 なお、図1に示すように、中継器30は病室201にも配置されているので、当然ながら病室201内での血管外漏出もナースステーション208内のナースへと知らせることができる。例えば、睡眠中に点滴が行われる場合に、寝ている間に注入針が血管から外れることで生じる血管外漏出も検出可能である。 As shown in FIG. 1, since the repeater 30 is also arranged in the hospital room 201, it is natural that the extravasation in the hospital room 201 can be notified to the nurse in the nurse station 208. For example, when an infusion is performed during sleep, extravasation caused by the injection needle coming off the blood vessel while sleeping can also be detected.
 本実施形態においては、また、血管外漏出の発生した時点での位置情報を検出ユニット20自体が認識し、その情報がコンソール40に向けて送信される構成としてもよい。
 薬液の投与が複数の患者に同時に行われている場合には、患者を識別するために、患者ごとのIDデータも併せて検出ユニット20から送信されるようになっていることが好ましい。
In the present embodiment, the position information at the time when extravasation occurs may be recognized by the detection unit 20 itself, and the information may be transmitted to the console 40.
When administration of a chemical solution is performed on a plurality of patients simultaneously, it is preferable that ID data for each patient is also transmitted from the detection unit 20 in order to identify the patient.
 また、中継器30が利用されない場合であっても、各階にコンソール40が設けられており、検出ユニット20からの情報が該ユニット20が存在する階(患者の居る階)のコンソール40によって受信される構成であれば、患者の詳細な位置を特定することはできなくても、少なくとも、患者が何階に居るかは特定することができる。 Even if the repeater 30 is not used, the console 40 is provided on each floor, and information from the detection unit 20 is received by the console 40 on the floor where the unit 20 exists (the floor where the patient is present). Even if it is not possible to specify the detailed position of the patient, it is possible to specify at least what floor the patient is on.
 また、検出ユニット20に、例えばLED又はスピーカといったアラーム手段が設けられており、該ユニット20が血管外漏出を検出した場合に、このアラーム手段が駆動される構成としてもよい。 Further, the detection unit 20 may be provided with alarm means such as an LED or a speaker, and the alarm means may be driven when the unit 20 detects extravasation.
 また、本システム1は、さらに、薬液投与の開始の時点から血管外漏出の発生の時点までの時間を記憶する機能を有していてもよい。このような構成によれば、薬液の投与を再開する場合に、残りどれくらいの量を投与すればよいかを良好に決定することができる。
 薬液投与の開始の時点から血管外漏出の発生の時点までの時間を計測する方法としては、一例として、検出ユニット20自体が時間を計測する機能を備え、薬液投与の開始から血管外漏出の発生までの時間を計測し、その情報がコンソール40に送信される構成であってもよい。あるいは、コンソール40が薬液投与の開始から血管外漏出の発生までの時間を計測できるようになっていてもよい。この時間の情報は、必要に応じて、ユニット20内又はコンソール40内に記憶されてもよい。
Further, the present system 1 may further have a function of storing the time from the start of drug administration to the occurrence of extravasation. According to such a configuration, when the administration of the drug solution is resumed, it is possible to satisfactorily determine how much of the remaining amount should be administered.
As an example of a method for measuring the time from the start of drug administration to the occurrence of extravasation, as an example, the detection unit 20 itself has a function of measuring the time, and the occurrence of extravasation from the start of drug administration The time until the time is measured and the information may be transmitted to the console 40. Alternatively, the console 40 may be able to measure the time from the start of drug solution administration to the occurrence of extravasation. This time information may be stored in the unit 20 or the console 40 as required.
(第2の実施形態)
 図5は、第2の実施形態の漏出検出システムの一部を示す図である。
 図5に示すように、本発明は、輸液ポンプを用いて薬液を投与する場合にも適用することができる。
(Second Embodiment)
FIG. 5 is a diagram illustrating a part of the leakage detection system according to the second embodiment.
As shown in FIG. 5, this invention is applicable also when administering a chemical | medical solution using an infusion pump.
 この薬液ポンプ90は、スタンド81に取り付けられて使用されるフィンガーポンプ(一例)であり、流量など所定の情報を表示するディスプレイ93、図示は省略するがチューブを加圧するフィンガー部、内蔵バッテリー等を有している。また、気泡センサー、圧力センサー、ドロップセンサー等が内蔵されていてもよい。 This chemical pump 90 is a finger pump (one example) that is used by being attached to a stand 81, and includes a display 93 that displays predetermined information such as a flow rate, a finger portion that pressurizes a tube, a built-in battery, etc., not shown. Have. Moreover, a bubble sensor, a pressure sensor, a drop sensor, etc. may be incorporated.
 図6に示すように、薬液ポンプ90は、種々の演算を行う演算部91、漏出検出ユニット20と有線又は無線接続されており該ユニット20からの血管外漏出の情報を受ける受信部95、その血管外漏出の情報を無線により外部に送信する送信部93、及び、フィンガー部に相当する駆動部97を有している。 As shown in FIG. 6, the chemical pump 90 includes a calculation unit 91 that performs various calculations, a reception unit 95 that is connected to the leak detection unit 20 by wire or wirelessly and receives information on extravasation from the unit 20, It has the transmission part 93 which transmits the information of extravascular leakage to the exterior by radio | wireless, and the drive part 97 corresponded to a finger part.
 このように構成された薬液ポンプ90では、検出ユニット20からの血管外漏出の情報を受信部95で受信し、その情報を送信部93を介してコンソール40(図1参照)に対して送信する。血管外漏出の情報を受信した場合、演算部91が駆動部97に対して駆動停止の信号を送るように構成されていてもよい。 In the chemical pump 90 configured as described above, the information on extravasation from the detection unit 20 is received by the receiving unit 95, and the information is transmitted to the console 40 (see FIG. 1) via the transmitting unit 93. . When the information on extravasation is received, the calculation unit 91 may be configured to send a drive stop signal to the drive unit 97.
 また、輸液ポンプ90は、第1の実施形態同様、該血管外漏出の情報とともに、血管外漏出が発生した時点における病院施設内での患者の位置情報を送信する機能を有していてもよい。 In addition, the infusion pump 90 may have a function of transmitting the position information of the patient in the hospital facility at the time when the extravasation occurs together with the extravasation information as in the first embodiment. .
 なお、図5の例では、輸液ポンプ90と漏出検出ユニット20とがコード28によって有線接続された構成を示している。この場合、輸液ポンプ90の内蔵バッテリーを検出ユニット20の電源として兼用することが可能である。また、血管外漏出が発生した場合に、輸液ポンプ90のディスプレイ93にその旨が表示されるようになっていてもよい。 Note that the example of FIG. 5 shows a configuration in which the infusion pump 90 and the leak detection unit 20 are connected to each other by a cord 28. In this case, the built-in battery of the infusion pump 90 can also be used as a power source for the detection unit 20. Further, when extravasation occurs, that fact may be displayed on the display 93 of the infusion pump 90.
 図7は、図3に示した漏出検出ユニット20の内蔵電池23の充電装置120を示す図である。
 この充電装置120は、電磁誘導を利用して検出ユニット20内の電池を充電する非接点式の充電器である。この例では、充電装置120は、複数の検出ユニット20が配置可能な略プレート状の保持部122を有している。保持部122内には送電コイル(不図示)が内蔵されており、一方の検出ユニット20内には受電コイル27(図3参照)が内蔵されている。
FIG. 7 is a diagram showing a charging device 120 for the built-in battery 23 of the leakage detection unit 20 shown in FIG.
The charging device 120 is a non-contact type charger that charges a battery in the detection unit 20 using electromagnetic induction. In this example, the charging device 120 includes a substantially plate-shaped holding unit 122 in which a plurality of detection units 20 can be arranged. A power transmission coil (not shown) is built in the holding unit 122, and a power reception coil 27 (see FIG. 3) is built in one detection unit 20.
 このような非接点式の充電装置によれば、漏出検出ユニット20に充電用の金属接点を設ける必要が無いため、特に、薬液の漏出を検出する本実施形態のユニット20に好適である。 According to such a non-contact type charging device, it is not necessary to provide a metal contact for charging in the leakage detection unit 20, and therefore, it is particularly suitable for the unit 20 of the present embodiment that detects leakage of a chemical solution.
 なお、充電装置120のプレート状の保持部122には、各ユニット20が嵌め込まれる凹部が設けられていてもよいし、充電の完了を示すLEDなどのインジケータが設けられていてもよい。 In addition, the plate-shaped holding part 122 of the charging device 120 may be provided with a recess into which each unit 20 is fitted, or may be provided with an indicator such as an LED that indicates completion of charging.
 以上、本発明の一形態について説明したが、「薬液」としては、抗ガン剤に限定されるものではなく、例えば一般的な栄養点滴剤であってもよい。
 血管外漏出を検出する原理としては、赤外線を利用するものの他にも、薬液の漏出による皮膚を膨らみを検出することで血管外漏出が発生したことを検出するものであってもよい。
As mentioned above, although one form of this invention was demonstrated, as a "chemical | medical solution", it is not limited to an anticancer agent, For example, a common nutrient drop may be sufficient.
As a principle for detecting extravasation, other than using infrared rays, it may be possible to detect the occurrence of extravasation by detecting swelling of the skin due to the leakage of the chemical solution.
 漏出検出ユニット20は、血管外漏出が発生した場合にのみ警告信号を送信してもよいし、あるいは、上記実施形態のように、血管外漏出が発生していなくても「漏出無し」を示す待機信号を送信する構成であってもよい。 The leak detection unit 20 may transmit a warning signal only when extravasation occurs, or indicates “no leak” even if no extravasation occurs as in the above embodiment. It may be configured to transmit a standby signal.
 患者の位置情報を検出するための方法としては、例えば、病院施設内に複数の中継器30が配置された構成において、無線通信を利用して、漏出検出ユニット20とそれら複数の中継器30の数台(例えば3台、または4台)との位置関係を算出し、さらに、それに基づいて測量を行うことで患者の位置情報を取得するものであってもよい。 As a method for detecting patient position information, for example, in a configuration in which a plurality of repeaters 30 are arranged in a hospital facility, the leakage detection unit 20 and the plurality of repeaters 30 can be connected using wireless communication. The positional relationship with several units (for example, three units or four units) may be calculated, and the patient position information may be acquired by performing surveying based on the calculated positional relationship.
 図8は、本発明のさらに他の形態の漏出検出ユニットの回路構成を模式的に示す図である。
 図8に示すように、この漏出検出ユニット20′は、種々の演算を行う制御部26と、それに接続された漏出検出用デバイス26a(第1の実施形態と同様、発光ダイオード等で構成されている)に加え、さらに、該制御部26に接続された温度センサ26bを有している。なお、この温度センサの代わりに光センサを利用してもよい。
FIG. 8 is a diagram schematically showing a circuit configuration of a leakage detection unit according to still another embodiment of the present invention.
As shown in FIG. 8, the leak detection unit 20 ′ includes a control unit 26 that performs various calculations, and a leak detection device 26a connected thereto (similar to the first embodiment, a light emitting diode or the like). And a temperature sensor 26b connected to the control unit 26. An optical sensor may be used instead of this temperature sensor.
 温度センサ26bは、ユニット20′の下面側(図3参照)に配置され、ユニット20′が患者の体に正常に貼り付けられているときには、患者の体表面の温度を測定する。ユニット20′が何らかの理由で患者の体から外れた(剥がれた)ときには、温度センサ26bは、体表面ではなく外気の温度(一例)を測定することとなる。
 温度センサ26bによるこの検出結果を用いることで、ユニット20′が患者の体に正常に取り付けられているかどうかを検出することができる。
The temperature sensor 26b is disposed on the lower surface side of the unit 20 ′ (see FIG. 3), and measures the temperature of the patient's body surface when the unit 20 ′ is normally attached to the patient's body. When the unit 20 'is removed from the patient's body for some reason (separated), the temperature sensor 26b measures the temperature of the outside air (one example) instead of the body surface.
By using this detection result by the temperature sensor 26b, it is possible to detect whether or not the unit 20 'is normally attached to the patient's body.
 上記構成の漏出検出ユニット20′を用いて次のような判定を行うことができる。
 まず、漏出検出用デバイス26aと温度センサ26bの検出結果がいずれも正常(漏出無し/人体温度)の場合、ユニット20′は正常に取り付けられ正常に動作していると判定される。デバイス26aの検出結果が異常(漏出有り)であり、センサ26bの検出結果が正常(人体温度)の場合、ユニット20′の取付けは正常であるが漏出が発生している判定される。また、デバイス26aとセンサ26bの検出結果がいずれも異常(漏出有り/外気温度)の場合、ユニット20′が患者の体から外れていると判定される。
The following determination can be performed by using the leakage detection unit 20 ′ having the above configuration.
First, when the detection results of the leakage detection device 26a and the temperature sensor 26b are both normal (no leakage / human body temperature), it is determined that the unit 20 'is normally attached and operating normally. If the detection result of the device 26a is abnormal (leakage is present) and the detection result of the sensor 26b is normal (human body temperature), it is determined that the unit 20 'is normally attached but leakage has occurred. Further, when both the detection results of the device 26a and the sensor 26b are abnormal (leakage / outside air temperature), it is determined that the unit 20 ′ is detached from the patient's body.
 上記のような構成によれば、血管外漏出だけでなく、漏出検出ユニット20′が患者の体に正常に取り付けられているかどうかも判定することができるので、より安全な薬液投与を行うことができる。 According to the above configuration, not only extravasation but also whether or not the leak detection unit 20 ′ is normally attached to the patient's body can be determined, so that safer drug administration can be performed. it can.
1 漏出検出システム
20、20′ 漏出検出ユニット
22a アンテナ
23 電池
26 制御部
26a 漏出検出用デバイス
26b 温度センサ
29 両面シート
30 中継器
40 センターコンソール
81 スタンド
83 薬液バッグ
85 チューブ
90 輸液ポンプ
101、201 病室
104、204 トイレ
108、208 ナースステーション
120 充電装置
DESCRIPTION OF SYMBOLS 1 Leak detection system 20, 20 'Leak detection unit 22a Antenna 23 Battery 26 Control part 26a Leak detection device 26b Temperature sensor 29 Double-sided sheet 30 Repeater 40 Center console 81 Stand 83 Chemical solution bag 85 Tube 90 Infusion pump 101, 201 Hospital room 104 204 Toilet 108, 208 Nurse station 120 Charging device

Claims (13)

  1.  患者に対し薬液を投与している際の血管外漏出を検出する漏出検出装置と、
     病院施設内に配置された監視端末と、
     前記漏出検出装置によって検出された血管外漏出の情報を無線により前記監視端末へ送信する送信手段と、
     を備える漏出検出システム。
    A leak detection device for detecting extravasation when administering a liquid medicine to a patient;
    A monitoring terminal located in the hospital facility;
    Transmitting means for wirelessly transmitting information on extravasation detected by the leak detection device to the monitoring terminal;
    A leakage detection system comprising:
  2.  前記血管外漏出の情報とともに、該血管外漏出が発生した時点における病院施設内での患者の位置情報が前記監視端末へ送信される、請求項1に記載の漏出検出システム。 The leak detection system according to claim 1, wherein the information on the position of the patient in the hospital facility at the time when the extravasation occurs is transmitted to the monitoring terminal together with the extravasation information.
  3.  さらに、
     前記薬液投与の開始から前記血管外漏出の発生までの時間を記憶する機能を有する、請求項1又は2に記載の漏出検出システム。
    further,
    The leak detection system according to claim 1, wherein the leak detection system has a function of storing a time from the start of the administration of the drug solution to the occurrence of the extravasation.
  4.  前記漏出検出装置が、
     患者の血管に向けて光線を照射する発光素子と、その反射光を受光する受光素子とを内蔵した、患者の体表面に取り付けられるユニットであり、
     さらに前記送信手段を内蔵している、請求項1~3のいずれか1項に記載の漏出検出システム。
    The leak detection device is
    It is a unit attached to the patient's body surface that contains a light emitting element that irradiates light toward the patient's blood vessel and a light receiving element that receives the reflected light.
    The leakage detection system according to any one of claims 1 to 3, further comprising the transmission means.
  5.  前記送信手段が、患者に対し薬液を投与するための輸液ポンプに設けられている、請求項1~4のいずれか1項に記載の漏出検出システム。 The leakage detection system according to any one of claims 1 to 4, wherein the transmission means is provided in an infusion pump for administering a drug solution to a patient.
  6.  前記送信手段から送信された情報を受信して該情報を前記監視端末に送る中継器が病院施設内に複数配置されており、
     前記患者の位置情報として該中継器の位置情報が前記監視端末に送られる、請求項1~5のいずれか1項に記載の漏出検出システム。
    A plurality of relays that receive the information transmitted from the transmitting means and send the information to the monitoring terminal are arranged in a hospital facility,
    The leakage detection system according to any one of claims 1 to 5, wherein the position information of the repeater is sent to the monitoring terminal as the position information of the patient.
  7.  前記中継器が、病院施設内の複数階に配置されている、請求項6に記載の漏出検出システム。 The leak detection system according to claim 6, wherein the repeater is arranged on a plurality of floors in a hospital facility.
  8.  前記監視端末が表示手段を有し、前記血管外漏出の情報を受信した際に該表示手段に警告メッセージが表示される、請求項1~7のいずれか1項に記載の漏出検出システム。 The leak detection system according to any one of claims 1 to 7, wherein the monitoring terminal includes a display unit, and a warning message is displayed on the display unit when the extravasation information is received.
  9.  前記薬液が抗ガン剤である、請求項1~8のいずれか1項に記載の薬液漏出システム。 The chemical solution leakage system according to any one of claims 1 to 8, wherein the chemical solution is an anticancer agent.
  10.  前記漏出検出装置が、
     患者の血管に向けて光線を照射する発光素子と、その反射光を受光する受光素子とを内蔵した、患者の体表面に取り付けられるユニットであり、
     さらに、
     該ユニットが患者の体表面に正常に取り付けられているかどうかを検出するための、温度センサ又は光センサを備えている、請求項1に記載の漏出検出システム。
    The leak detection device is
    It is a unit attached to the patient's body surface that contains a light emitting element that irradiates light toward the patient's blood vessel and a light receiving element that receives the reflected light.
    further,
    The leak detection system according to claim 1, comprising a temperature sensor or a light sensor for detecting whether the unit is normally attached to the patient's body surface.
  11.  患者に対し薬液を投与するための輸液ポンプであって、
     患者に対し薬液を投与している際の血管外漏出を検出するための漏出検出装置から送信された前記血管外漏出の情報を受ける受信部と、
     前記血管外漏出の情報を無線により病院施設内に配置された監視端末に送信する送信部と、を備える輸液ポンプ。
    An infusion pump for administering a drug solution to a patient,
    A receiving unit for receiving information on the extravasation transmitted from the leak detection device for detecting extravasation when administering a drug solution to a patient;
    An infusion pump comprising: a transmitter that wirelessly transmits the extravasation information to a monitoring terminal arranged in a hospital facility.
  12.  前記送信部が、
     前記血管外漏出の情報とともに、該血管外漏出が発生した時点における病院施設内での患者の位置情報を前記監視端末に送信する、請求項11に記載の輸液ポンプ。
    The transmitter is
    The infusion pump according to claim 11, wherein information on the position of a patient in a hospital facility at the time when the extravasation occurs is transmitted to the monitoring terminal together with the extravasation information.
  13.  前記血管外漏出が検出されたときに注入動作が自動停止される、請求項11又は12に記載の輸液ポンプ。 The infusion pump according to claim 11 or 12, wherein the infusion operation is automatically stopped when the extravasation is detected.
PCT/JP2009/069564 2008-11-19 2009-11-18 Leak detection system WO2010058796A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010539240A JP5897798B2 (en) 2008-11-19 2009-11-18 Leak detection system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008295730 2008-11-19
JP2008-295730 2008-11-19

Publications (1)

Publication Number Publication Date
WO2010058796A1 true WO2010058796A1 (en) 2010-05-27

Family

ID=42198235

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2009/069564 WO2010058796A1 (en) 2008-11-19 2009-11-18 Leak detection system

Country Status (2)

Country Link
JP (2) JP5897798B2 (en)
WO (1) WO2010058796A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012020507A1 (en) * 2010-08-13 2012-02-16 日本協能電子株式会社 Liquid leakage detection system
WO2012111157A1 (en) * 2011-02-18 2012-08-23 日本協能電子株式会社 Liquid detection device
JPWO2012133845A1 (en) * 2011-03-31 2014-07-28 株式会社根本杏林堂 Leak detection sensor and chemical injection system
JP2018522634A (en) * 2015-06-19 2018-08-16 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Control device and control method for controlling medical system, portable device, facility and computer program product
JP7295039B2 (en) 2017-06-16 2023-06-20 ケアフュージョン 303、インコーポレイテッド opioid management system
US11823792B2 (en) 2018-05-04 2023-11-21 Carefusion 303, Inc. Peer community based anomalous behavior detection

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019130243A (en) * 2018-02-02 2019-08-08 王子ホールディングス株式会社 Information processing system, notification system, information processing method, notification method, and absorbent article
WO2021168076A1 (en) 2020-02-21 2021-08-26 Bayer Healthcare Llc Fluid path connectors for medical fluid delivery
CA3228205A1 (en) 2020-04-30 2021-11-04 Bayer Healthcare Llc System, device, and method for safeguarding wellbeing of patients for fluid injection
IL299062A (en) 2020-06-18 2023-02-01 Bayer Healthcare Llc In-line air bubble suspension apparatus for angiography injector fluid paths

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002011095A (en) * 2000-06-28 2002-01-15 Oi Electric Co Ltd Instillation monitoring device and its system
WO2006030764A1 (en) * 2004-09-14 2006-03-23 Nemoto Kyorindo Co., Ltd. Leakage detector
JP2008047097A (en) * 2006-06-28 2008-02-28 Sysmex Corp Patient abnormality notification system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7047058B1 (en) * 2001-02-06 2006-05-16 Medrad, Inc. Apparatuses, systems and methods for extravasation detection
JP4393461B2 (en) * 2003-11-26 2010-01-06 株式会社日立メディコ Biological light measurement apparatus and method
JP2008000218A (en) * 2006-06-20 2008-01-10 Moritex Corp Loosened needle detection sensor for indwelling needle
WO2008075768A1 (en) * 2006-12-21 2008-06-26 Panasonic Corporation Blood sensor and blood inspection device using it

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002011095A (en) * 2000-06-28 2002-01-15 Oi Electric Co Ltd Instillation monitoring device and its system
WO2006030764A1 (en) * 2004-09-14 2006-03-23 Nemoto Kyorindo Co., Ltd. Leakage detector
JP2008047097A (en) * 2006-06-28 2008-02-28 Sysmex Corp Patient abnormality notification system

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5734296B2 (en) * 2010-08-13 2015-06-17 日本協能電子株式会社 Liquid leak detection system
CN103429283A (en) * 2010-08-13 2013-12-04 日本协能电子股份有限公司 Liquid leakage detection system
WO2012020507A1 (en) * 2010-08-13 2012-02-16 日本協能電子株式会社 Liquid leakage detection system
US8946501B2 (en) 2010-08-13 2015-02-03 Aqua Power System, Japan Liquid leakage detection system
WO2012111157A1 (en) * 2011-02-18 2012-08-23 日本協能電子株式会社 Liquid detection device
JP5968872B2 (en) * 2011-03-31 2016-08-10 株式会社根本杏林堂 Leak detection sensor and chemical injection system
JPWO2012133845A1 (en) * 2011-03-31 2014-07-28 株式会社根本杏林堂 Leak detection sensor and chemical injection system
JP2016190069A (en) * 2011-03-31 2016-11-10 株式会社根本杏林堂 Leak detecting sensor and chemical liquid injection system
US9905721B2 (en) 2011-03-31 2018-02-27 Nemoto Kyorindo Co., Ltd. Leak detecting sensor and chemical liquid injection system
JP2018522634A (en) * 2015-06-19 2018-08-16 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Control device and control method for controlling medical system, portable device, facility and computer program product
JP2021100627A (en) * 2015-06-19 2021-07-08 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト Control apparatus and method for controlling medical system, portable device, arrangement, and computer program product
JP7295039B2 (en) 2017-06-16 2023-06-20 ケアフュージョン 303、インコーポレイテッド opioid management system
US11823792B2 (en) 2018-05-04 2023-11-21 Carefusion 303, Inc. Peer community based anomalous behavior detection

Also Published As

Publication number Publication date
JP2016093530A (en) 2016-05-26
JPWO2010058796A1 (en) 2012-04-19
JP5897798B2 (en) 2016-03-30

Similar Documents

Publication Publication Date Title
JP5897798B2 (en) Leak detection system
KR101156967B1 (en) Analyte monitoring system with wireless alarm
US8700133B2 (en) Apparatus and method for monitoring catheter insertion
JP2006015146A (en) Method for monitoring concentration of analyte
US9597482B2 (en) Apparatus and method for monitoring catheter insertion
JP2012254121A (en) Wireless communication system
US20220118240A1 (en) System, Method, and Product for Event Monitoring
JP2023083324A (en) System, method, and product for identifying lumen
US10276038B2 (en) Remote notification system for medical devices
KR20150000710A (en) Remote controllable automated external defibrillator and method of controlling the same
KR20170104295A (en) Device for sensing ringer's solution
CN105877724A (en) Portable invasive pressure sensor
US10453323B2 (en) Remote notification system for medical devices
CN210992280U (en) Infusion early warning system
US11964125B2 (en) Drug solution injection system, drug solution injection device, drug solution injection method, and program
KR20110106537A (en) Observation and management system for giving ringer
US20140081155A1 (en) Methods And Apparatus for Wireless Electrode Having Power Conservation
CN110665084A (en) Multi-path drip infusion system and infusion method
JP2018023557A (en) Dripping notification system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09827577

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2010539240

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09827577

Country of ref document: EP

Kind code of ref document: A1